Our results showed that BB treatment reduced the expression of Collagen I, fibronectin, α-SMA, and TGF-β1, indicating that BB might reduce these fibrogenic proteins by inhibiting TGF-β1 expression, thereby relieving IPF. The gene discussed is FN1; the disease is idiopathic pulmonary fibrosis.